Titre : Syndécane-3

Syndécane-3 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Predictive Value of Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndécane-3 : Questions médicales les plus fréquentes", "headline": "Syndécane-3 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndécane-3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndécane-3" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Syndécanes", "url": "https://questionsmedicales.fr/mesh/D053667", "about": { "@type": "MedicalCondition", "name": "Syndécanes", "code": { "@type": "MedicalCode", "code": "D053667", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.550.847" } } }, "about": { "@type": "MedicalCondition", "name": "Syndécane-3", "alternateName": "Syndecan-3", "code": { "@type": "MedicalCode", "code": "D053670", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Addolorata Pisconti", "url": "https://questionsmedicales.fr/author/Addolorata%20Pisconti", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, IIB, University of Liverpool, Liverpool, UK." } }, { "@type": "Person", "name": "Martin Götte", "url": "https://questionsmedicales.fr/author/Martin%20G%C3%B6tte", "affiliation": { "@type": "Organization", "name": "Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1, D11, 48149 Muenster, Germany." } }, { "@type": "Person", "name": "Ilona Kovalszky", "url": "https://questionsmedicales.fr/author/Ilona%20Kovalszky", "affiliation": { "@type": "Organization", "name": "Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary." } }, { "@type": "Person", "name": "Samantha Arokiasamy", "url": "https://questionsmedicales.fr/author/Samantha%20Arokiasamy", "affiliation": { "@type": "Organization", "name": "Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom." } }, { "@type": "Person", "name": "James R Whiteford", "url": "https://questionsmedicales.fr/author/James%20R%20Whiteford", "affiliation": { "@type": "Organization", "name": "Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.", "datePublished": "2023-10-02", "url": "https://questionsmedicales.fr/article/37783044", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/07853890.2023.2261111" } }, { "@type": "ScholarlyArticle", "name": "Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98.", "datePublished": "2022-09-28", "url": "https://questionsmedicales.fr/article/36248875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.977443" } }, { "@type": "ScholarlyArticle", "name": "Positive Predictive Value of Diagnosis Codes for Hidradenitis Suppurativa and Cutaneous Abscess.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36538899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000528752" } }, { "@type": "ScholarlyArticle", "name": "Positive Predictive Value of Primary Subarachnoid Hemorrhage Diagnoses on Death Certificates.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36149053", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.25011/cim.v45i3.38874" } }, { "@type": "ScholarlyArticle", "name": "Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36581427", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-065568" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Glycoprotéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008562" }, { "@type": "ListItem", "position": 6, "name": "Syndécanes", "item": "https://questionsmedicales.fr/mesh/D053667" }, { "@type": "ListItem", "position": 7, "name": "Syndécane-3", "item": "https://questionsmedicales.fr/mesh/D053670" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndécane-3 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndécane-3", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndécane-3", "description": "Comment diagnostiquer une anomalie du syndécane-3 ?\nQuels examens sont utilisés pour évaluer le syndécane-3 ?\nLe dosage sanguin peut-il aider au diagnostic ?\nQuels marqueurs sont associés au syndécane-3 ?\nLe diagnostic est-il difficile à établir ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndécane-3", "description": "Quels symptômes sont liés à une dysfonction du syndécane-3 ?\nLe syndécane-3 est-il lié à des maladies spécifiques ?\nPeut-on observer des symptômes cutanés ?\nY a-t-il des symptômes systémiques associés ?\nLes symptômes varient-ils d'un patient à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndécane-3", "description": "Peut-on prévenir les dysfonctionnements du syndécane-3 ?\nY a-t-il des facteurs de risque connus ?\nDes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle le syndécane-3 ?\nLe stress a-t-il un impact sur le syndécane-3 ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndécane-3", "description": "Quels traitements ciblent le syndécane-3 ?\nLe traitement est-il efficace ?\nY a-t-il des effets secondaires des traitements ?\nDes traitements expérimentaux existent-ils ?\nLe suivi est-il nécessaire après traitement ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndécane-3", "description": "Quelles complications peuvent survenir avec le syndécane-3 ?\nLe syndécane-3 est-il lié à des complications cardiovasculaires ?\nDes complications neurologiques sont-elles possibles ?\nComment gérer les complications liées au syndécane-3 ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndécane-3", "description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il les risques ?\nLes infections jouent-elles un rôle ?\nY a-t-il un lien avec l'obésité ?\nLes facteurs environnementaux sont-ils significatifs ?", "url": "https://questionsmedicales.fr/mesh/D053670?mesh_terms=Predictive+Value+of+Tests&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie du syndécane-3 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des analyses de tissus pour évaluer l'expression du syndécane-3." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le syndécane-3 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies et des analyses immunohistochimiques peuvent être réalisées pour évaluer le syndécane-3." } }, { "@type": "Question", "name": "Le dosage sanguin peut-il aider au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de dosage sanguin standardisé pour le syndécane-3." } }, { "@type": "Question", "name": "Quels marqueurs sont associés au syndécane-3 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs tumoraux et des cytokines peuvent être associés à l'expression du syndécane-3." } }, { "@type": "Question", "name": "Le diagnostic est-il difficile à établir ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diagnostic peut être complexe en raison de la variabilité de l'expression du syndécane-3." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysfonction du syndécane-3 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des troubles de l'adhésion cellulaire et des anomalies tissulaires." } }, { "@type": "Question", "name": "Le syndécane-3 est-il lié à des maladies spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est impliqué dans des maladies comme le cancer et les maladies inflammatoires." } }, { "@type": "Question", "name": "Peut-on observer des symptômes cutanés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies cutanées peuvent survenir en raison de l'implication du syndécane-3 dans la peau." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes systémiques comme la fatigue et la douleur peuvent être observés dans certains cas." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'un patient à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier considérablement selon l'individu et la pathologie associée." } }, { "@type": "Question", "name": "Peut-on prévenir les dysfonctionnements du syndécane-3 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire certains risques associés." } }, { "@type": "Question", "name": "Y a-t-il des facteurs de risque connus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'inflammation chronique et des prédispositions génétiques sont identifiés." } }, { "@type": "Question", "name": "Des dépistages réguliers sont-ils recommandés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des dépistages peuvent être recommandés pour les personnes à risque élevé de maladies associées." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le syndécane-3 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut influencer positivement l'expression du syndécane-3." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le syndécane-3 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter l'expression du syndécane-3 et contribuer à des maladies." } }, { "@type": "Question", "name": "Quels traitements ciblent le syndécane-3 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées et des anticorps monoclonaux peuvent être utilisés pour cibler le syndécane-3." } }, { "@type": "Question", "name": "Le traitement est-il efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité du traitement dépend de la pathologie et de l'expression du syndécane-3." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires des traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent entraîner des effets secondaires comme des réactions immunitaires." } }, { "@type": "Question", "name": "Des traitements expérimentaux existent-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements expérimentaux sont en cours d'évaluation pour cibler le syndécane-3." } }, { "@type": "Question", "name": "Le suivi est-il nécessaire après traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour évaluer la réponse au traitement et ajuster si nécessaire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le syndécane-3 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des métastases tumorales et des troubles immunitaires peuvent survenir." } }, { "@type": "Question", "name": "Le syndécane-3 est-il lié à des complications cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études suggèrent un lien entre le syndécane-3 et des complications cardiovasculaires." } }, { "@type": "Question", "name": "Des complications neurologiques sont-elles possibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines recherches indiquent que des complications neurologiques peuvent être associées." } }, { "@type": "Question", "name": "Comment gérer les complications liées au syndécane-3 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies inflammatoires." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques." } }, { "@type": "Question", "name": "Les infections jouent-elles un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections chroniques peuvent augmenter le risque de dysfonction du syndécane-3." } }, { "@type": "Question", "name": "Y a-t-il un lien avec l'obésité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est un facteur de risque reconnu pour des dysfonctionnements associés au syndécane-3." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des polluants environnementaux peut influencer l'expression du syndécane-3." } } ] } ] }

Sources (10000 au total)

Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.

This study aimed to evaluate the diagnostic value of a non-invasive methylation gene test in clinical colorectal tumour screening.... The quantitative methylation-specific PCR technique was used to detect faecal methylated syndecan-2 (mSDC2) in patients who received the screening of colorectal cancer (CRC).To evaluate the positive p... The PPV of CRC, CRC + AA and CRN in male patients were 28.03%, 43.55% and 56.24%, respectively, which were higher than female patients. The positive detection rate of mSDC2 and the PPV of CRC graduall... The mSDC2 test has a higher PPV in patients with colorectal cancer and colorectal adenoma (AD), especially in high-risk groups over 50 years of age, and may help in the early diagnosis of colorectal t...

Positive Predictive Value of Diagnosis Codes for Hidradenitis Suppurativa and Cutaneous Abscess.

Requisite to the application of clinical databases for observational research in hidradenitis suppurativa (HS) is the identification of an accurate case cohort. There is limited information on the val... The objective of the study was to assess the validity in utilizing diagnosis codes to establish the HS and CA cohorts from an integrated health system clinical database.... In this retrospective study, we evaluated a case-finding algorithm for HS which included the presence of at least one diagnosis code for HS and no diagnosis codes for CA of the axilla, groin, perineum... Among 100 HS patients, median age (interquartile range) in the HS cohort was 33 (24.75, 43.25) years. HS patients were predominantly female (82%) and white (70%). Median age among 100 CA patients was ... The case-finding algorithms employing at least one diagnosis code for HS and CA of the axilla, groin, perineum, or buttock, with the exclusion of the other's diagnosis codes, has good to strong PPV an...

Positive Predictive Value of Primary Subarachnoid Hemorrhage Diagnoses on Death Certificates.

Epidemiological studies of primary subarachnoid hemorrhage (pSAH) frequently include population-based death registries for case finding. The positive predictive value of pSAH diagnoses in death regist... This cross-sectional study identified all people in Ontario, Canada with pSAH listed as a cause of death between 2013 and 2017. pSAH was classified as "very likely" if diagnosis of pSAH was confirmed ... 1,613 deaths attributed to pSAH were identified (mean 322/year). pSAH classification frequencies were as follows: very likely 528 (32.7%); very unlikely 433 (26.8%); and status unknown 652 (40.4%).... We found that a quarter of pSAH cases in our province's death registry were very unlikely to be true pSAH while 40% had unknown veracity. These data should be considered when using death registries fo...

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study.

To determine the negative predictive value (NPV) of the FebriDx point-of-care host response device in patients presenting with symptoms suggestive of COVID-19 infection in a mostly immunised Australia... Observational diagnostic accuracy study comparing FebriDx point-of-care test to SARS-CoV-2 PCR.... An ED in Melbourne, Australia, with 63 000 annual presentations in 2021.... Patients aged 16 and over who met the Victorian Department of Health case definition for suspected COVID-19 infection PCR testing. Patients meeting any of the following criteria were excluded: <16 yea... COVID-19 PCR results (detected, not detected) and FebriDx results (bacterial positive, viral negative, viral positive).... 94 participants were enrolled (female: 46; male: 48), 34% of participants (tested positive for COVID-19 according to PCR results, with a background incidence among all adult ED attenders of 2.5%. The ... In the context of a population with low COVID-19 infection rates, an evolved variant of COVID-19 and a very high community COVID-19 vaccination rate, FebriDx demonstrated reduced sensitivity and NPV r... ACTRN12620001029987 (Australian Clinical Trials)....

Positive Predictive Value of Endoscopic Findings to Diagnose Vocal Fold Paresis.

Laryngoscopy corresponding with laryngeal electromyography (LEMG) is essential in diagnosing vocal fold paresis. However, baseline asymmetry or other diseases oftentimes confound the exam, making diag... We performed a retrospective review of patients with laryngeal asymmetry on laryngoscopy. Patients were divided into two groups: those with consistent paresis triad findings across all pitches and int... Twelve patients met inclusion criteria (age 50 +/-15, 7F:5M). Nine had the paresis triad. Three had an inconsistent triad. All patients with the paresis triad had LEMG findings consistent with neurolo... Our findings suggest the proposed laryngoscopic paresis triad may be useful objective criteria to diagnose paresis without the need for LEMG. Further prospective studies should examine a larger series... 4 Laryngoscope, 133:1712-1716, 2023....

Positive predictive value of humeral fractures in the Danish National Patient Registry.

The purpose of this study was to validate the humeral fracture diagnoses for adults in the Danish National Patient Registry (DNPR).... This was a population-based validity study, including adult patients (≥ 18 years) with a humeral fracture referred to the emergency department of hospitals in three Danish regions from March 2017 to F... In total, 661 patients were sampled between all available diagnosis codes. Overall, the PPV for humeral fracture was 89.3% (95% CI: 86.6-91.4%). PPVs for the subdivision codes were 91.0% (95% CI: 84.0... The validity of the humeral fracture diagnosis and the classifications of proximal and diaphyseal fractures in the DNPR is high, and the DNPR may therefore be used in registry research. Diagnosis of d... none.... not relevant....

Discriminative value of different combinations of tests to detect unilateral neglect in patients with right hemisphere damage.

This study was undertaken to assess the most sensitive combination of tests to detect peripersonal unilateral neglect (UN) after stroke.... The present study is a secondary analysis of a previously reported multicentric study of 203 individuals with right hemisphere damage (RHD), mainly subacute stroke, 11 weeks postonset on average, and ... A combination of four z-scores based on the following three tests provided good discrimination of patients with RHD from matched healthy controls: the starting point and the difference between the num... The most sensitive and parsimonious combination of tests to detect UN after stroke relies on four scores from three simple tests (bells test, line bisection, and reading). Future study is warranted to...